Quarterly Result2 May 2026, 05:21 pm
Bansisons Tea: Audited Results for FY26, Auditor's Report
AI Summary
Bansisons Tea Industries Ltd (now Novyra Pharmachem Limited) announced its audited financial results for the quarter and year ended March 31, 2026, along with the auditor's report. The Board of Directors approved the standalone audited financial results in a meeting held on May 02, 2026. M/s DGMS & Co. LLP, Chartered Accountants, issued an audit report with an unmodified opinion. The company's outstanding loans/revolving facilities from banks/financial institutions as of March 31, 2026, stood at ₹145.88 Lakh.
Key Highlights
- Bansisons Tea Industries Ltd (Novyra Pharmachem) reports audited financial results for FY26.
- Auditors M/s DGMS & Co. LLP issued an unmodified opinion on the financial results.
- Board meeting approved results on May 02, 2026, as per SEBI regulations.
- Outstanding loans/revolving facilities from banks/financial institutions at ₹145.88 Lakh.
Price Impact
More from BANSTEA